Impact Of Missing ePRO Data On Clinical Trials

By Jennifer Ross, Lead Biostatistician and Elisa Holzbaur, Manager, ePRO Services, Almac Group
The quality of electronic Patient Reported Outcome (ePRO) data far exceeds that of data collected on paper, as various forms of missing data can be prevented. However, even with automated reminders, patients may still be non-compliant with ePRO assessments, leading to missing data.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more